What is the latest research on bipolar disorder?

Trial Tests New Technique to Manage Mood Swings Within Bipolar Disorder. Aug. 5, 2021 — Researchers have conducted a new trial to identify how an existing psychological therapy can be adapted to help people cope with and manage frequent bipolar mood …

Are there any new treatments for bipolar disorder?

Caplyta is now FDA-approved for depressive episodes from bipolar I and II. The US Food and Drug Administration (FDA) has approved Caplyta (lumateperone) for the treatment of bipolar depression in adults.

Can I qualify for disability with bipolar?

Bipolar disorder is included in the Social Security Listings of Impairments, which means that if your illness has been diagnosed by a qualified medical practitioner and is severe enough to keep you from working, you are eligible to receive disability benefits.

What is the first line drug for bipolar disorder?

First-line treatments for bipolar depressive episodes include lithium or lamotrigine monotherapy. For more severe cases, can add second mood stabilizer (e.g., lamotrigine combined with lithium or divalproex). Atypical antipsychotics can be added for patients with psychotic features (e.g., delusions, hallucinations).

What does science say about bipolar disorder?

Bipolar disorder is widely believed to be the result of chemical imbalances in the brain. The chemicals responsible for controlling the brain’s functions are called neurotransmitters, and include noradrenaline, serotonin and dopamine.

Is Wellbutrin good for bipolar?

Bupropion is widely used for treating bipolar disorder (BD), and especially those with depressive mood, based on its good treatment effect, safety profile, and lower risk of phase shifting. However, increasing evidence indicates that the safety of bupropion in BD patients may not be as good as previously thought.

What is the strongest established risk factor for bipolar disorder?

Results: Frequent ‘ups and downs’ of mood were the strongest risk factor for both bipolar and depressive disorders; a weaker risk factor for both was emotional/vegetative lability (neuroticism).